Amoxycillin (Promoxil, Promoxil S, Promoxil Sf)
Amoxycillin
Medpro Pharmaceutica (Pty) Ltd
Registration
- Applicant
- Medpro Pharmaceutica (Pty) Ltd
- Registrations
- 4
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Promoxil 250 EACH CAPSULE CONTAINS AMOXYCILLIN TRIHYDRATE 250,0 mg | 250 | 28023928/20.1.2/0239 | Cancelled | Not determined | None |
| Promoxil 500* EACH CAPSULE CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO 250,0 mg AMOXYCILLIN | 500 | 28024028/20.1.2/0240 | Registered | Not determined | None |
| Promoxil s EACH 5 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO 125 mg AMOXYCILLIN | Not listed | 28026928/20.1.2/0269 | Registered | Not determined | None |
| Promoxil sf EACH 5 ml SUSPENSION CONTAINS AMOXYCILLIN TRIHYDRATE EQUIVALENT TO AMOXYCILLIN 250 mg | Not listed | 28027028/20.1.2/0270 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 33613.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.